Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RFA for liver tumors: does it really work?

Heather Higgins1, David L Berger

  • 1Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

The Oncologist
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell transcriptomics reveals the impact of sex and age in the healthy human liver.

JHEP reports : innovation in hepatology·2026
Same author

Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation.

Cancer journal (Sudbury, Mass.)·2025
Same author

Is end-to-end or side-to-end anastomotic configuration associated with risk of positive intraoperative air leak test in left-sided colon and rectal resections for colon and rectal cancers?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2024
Same author

Comparison of conventional resection to D3 lymphadenectomy in right-sided colon cancer: A retrospective cohort study.

American journal of surgery·2024
Same author

Causes of death in patients operated for colorectal cancer.

Surgery·2024
Same author

Incidence of Secondary Cancers After Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

The Journal of surgical research·2023
Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
Same journal

Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

The oncologist·2026
See all related articles

Radiofrequency ablation (RFA) is increasingly used for liver tumors. Its role compared to surgery needs further study, but RFA offers palliative and potentially curative options.

Area of Science:

  • Oncology
  • Interventional Radiology

Background:

  • Radiofrequency ablation (RFA) is increasingly utilized for treating primary and metastatic liver tumors.
  • The precise role of RFA in patients eligible for surgery remains undefined.

Purpose of the Study:

  • To evaluate the current and future role of radiofrequency ablation in liver tumor treatment.
  • To determine if RFA can serve as a surgical alternative in specific patient groups.

Main Methods:

  • Review of current clinical practices and existing literature on RFA for hepatic tumors.
  • Identification of areas requiring further investigation through prospective studies.

Main Results:

  • RFA is a growing treatment modality for liver malignancies.

Related Experiment Videos

  • Further research is necessary to establish RFA's comparative efficacy against surgical intervention.

    • Conclusions:

    • Radiofrequency ablation technology is advancing and provides palliative and potentially curative benefits for liver tumors.
    • Prospective studies are essential to define RFA's role as an alternative to surgery in select patient populations.